A Study to Investigate if Long Acting Cabotegravir (CAB) and Lenacapavir (LEN) Injections Are Tolerable and Acceptable When Administered to Healthy Adults Without HIV
Clinical trial NCT06970223 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06970223
- Sponsor
- ViiV Healthcare
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-22
- Primary completion
- 2025-07-15
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.